Making your science more efficient and effective
In 1993, Medical and Biological Laboratories Co, Ltd (MBL), one of the leading biotechnology companies in Japan, established its U.S. – based subsidiary, MBL International Corporation (MBLI) in Boston to market and sell basic research reagents.
MBLI has since expanded its business and developed a worldwide network of distributors in North America, South America, and Europe. Our focus is on research reagents in immunology and molecular biology as well as diagnostic reagents in autoimmune disease, infectious disease, and virology. Based on antibody technology and immunology, we have widened our business to genetic tests, tumor markers, genomics, epigenetics, proteomics, oncology, metabolism and regenerative medicine.
MBL International Corporation at a Glance